Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
Authors
Keywords
Galectin-3, Hepatocellular carcinoma, Angiogenesis, Apoptosis, Prognostic factor
Journal
Journal of Translational Medicine
Volume 12, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-09-26
DOI
10.1186/s12967-014-0273-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia
- (2013) C.-L. Cheng et al. BLOOD
- Increased Circulation of Galectin-3 in Cancer Induces Secretion of Metastasis-Promoting Cytokines from Blood Vascular Endothelium
- (2013) C. Chen et al. CLINICAL CANCER RESEARCH
- Claudin-1 as a promoter of EMT in hepatocellular carcinoma
- (2013) J Stebbing et al. ONCOGENE
- Galectin-3 Silencing Inhibits Epirubicin-Induced ATP Binding Cassette Transporters and Activates the Mitochondrial Apoptosis Pathway via β-Catenin/GSK-3β Modulation in Colorectal Carcinoma
- (2013) Yung-Kuo Lee et al. PLoS One
- Galectin-3 gene silencing inhibits migration and invasion of human tongue cancer cells in vitro via downregulating β-catenin
- (2012) Dong Zhang et al. ACTA PHARMACOLOGICA SINICA
- Galectin-3 Contributes to Melanoma Growth and Metastasis via Regulation of NFAT1 and Autotaxin
- (2012) R. R. Braeuer et al. CANCER RESEARCH
- Epigenetic Regulation of Galectin-3 Expression by β1 Integrins Promotes Cell Adhesion and Migration
- (2012) Coert Margadant et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Galectin-3 Protein Regulates Mobility of N-cadherin and GM1 Ganglioside at Cell-Cell Junctions of Mammary Carcinoma Cells
- (2012) Cécile Boscher et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis
- (2012) Enza Piccolo et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- CCL2, Galectin-3, and SMRP Combination Improves the Diagnosis of Mesothelioma in Pleural Effusions
- (2012) Christophe Blanquart et al. Journal of Thoracic Oncology
- Galectin-3 regulates p21 stability in human prostate cancer cells
- (2012) Y Wang et al. ONCOGENE
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Galectin-3 Facilitates Cell Motility in Gastric Cancer by Up-Regulating Protease-Activated Receptor-1(PAR-1) and Matrix Metalloproteinase-1(MMP-1)
- (2011) Seok-Jun Kim et al. PLoS One
- Diagnostic Utility of Galectin-3 in Thyroid Cancer
- (2010) Connie G. Chiu et al. AMERICAN JOURNAL OF PATHOLOGY
- Tumor targeting and SPECT imaging properties of an 111In-labeled galectin-3 binding peptide in prostate carcinoma
- (2009) Susan L. Deutscher et al. NUCLEAR MEDICINE AND BIOLOGY
- Identification of Galectin-3 and Mucin-Type O-Glycans in Breast Cancer and Its Metastasis to Brain
- (2008) M. A. Mayoral et al. CANCER INVESTIGATION
- Tumor-Associated Galectin-3 Modulates the Function of Tumor-Reactive T Cells
- (2008) W. Peng et al. CANCER RESEARCH
- Genetic assessment of the importance of galectin-3 in cancer initiation, progression, and dissemination in mice
- (2008) Isabelle Eude-Le Parco et al. GLYCOBIOLOGY
- Expression of galectin-3 involved in prognosis of patients with hepatocellular carcinoma
- (2008) Yasunori Matsuda et al. HEPATOLOGY RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now